An antibiotic order form intervention does not improve or reduce vancomycin use

Pediatric Infectious Disease Journal

Volumn 24, Issue 12, 2005, Pages 1053-1058

  Bolon, Maureen K ^a   Arnold, Alana D ^b   Feldman, Henry A ^b   Goldmann, Donald A ^b   Wright, Sharon B ^c  

^a NORTHWESTERN UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Drug utilization review; Practice guidelines; Vancomycin

Indexed keywords

ANTIBIOTIC AGENT; VANCOMYCIN;

CHILD; CONTROLLED STUDY; DRUG COST; DRUG MISUSE; DRUG USE; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT COMPLIANCE; PEDIATRIC HOSPITAL; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; TERTIARY HEALTH CARE; UNIVARIATE ANALYSIS; WRITING;

EID: 29444453374     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000190025.61037.6c     Document Type: Article

References (32)

1. Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control. 1995;23:87-94.
2. Drinkovic D, Taylor SL, Pottumarthy S, Morris AJ. Prospective vancomycin audit in Auckland healthcare hospitals. NZ Med J. 1999;112:336-339.
3. You JH, Lyon DJ, Lee BS, Kwan SM, Tang HY. Vancomycin utilization at a teaching hospital in Hong Kong. Am J Health Syst Pharm. 2001;58:2167-2169.
4. Beidas S, Khamesian M. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol. 1996;17:773-774.
5. Watanakunakorn C. Prescribing pattern of vancomycin in a community teaching hospital with low prevalence of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol. 1997;18:767-769.
6. Cieslak PR, Strausbaugh LJ, Fleming DW, Ling JM. Vancomycin in Oregon: who's using it and why. Infect Control Hosp Epidemiol. 1999;20:557-560.
7. Green K, Schulman G, Haas DW, Schaffner W, D'Agata EM. Vancomycin prescribing practices in hospitalized chronic hemodialysis patients. Am J Kidney Dis. 2000;35:64-68.
8. Johnson SV, Hoey LL, Vance-Bryan K. Inappropriate vancomycin prescribing based on criteria from the Centers for Disease Control and Prevention. Pharmacotherapy. 1995;15:579-585.
9. Roghmann MC, Perdue BE, Polish L. Vancomycin use in a hospital with vancomycin restriction. Infect Control Hosp Epidemiol. 1999;20:60-63.
10. Singer MV, Haft R, Barlam T, Aronson M, Shafer A, Sands KE. Vancomycin control measures at a tertiary-care hospital: impact of interventions on volume and patterns of use. Infect Control Hosp Epidemiol. 1998;19:248-253.
11. Evans ME, Kortas KJ. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines. Infect Control Hosp Epidemiol. 1996;17:356-359.
12. Shah SS, Sinkowitz-Cochran RL, Keyserling HL, Jarvis WR. Vancomycin use in pediatric neurosurgery patients. Am J Infect Control. 1999;27:482-487.
13. Kahyaoglu O, Akpinar M, Nolan B, Inoue S, Zureikat G, Kumar A. Vancomycin use and monitoring in pediatric patients in a community hospital. Infect Control Hosp Epidemiol. 1998;19:299,301.
14. Hopkins HA, Sinkowitz-Cochran RL, Rudin BA, Keyserling HL, Jarvis WR. Vancomycin use in pediatric hematology-oncology patients. Infect Control Hosp Epidemiol. 2000;21:48-50.
15. Logsdon BA, Lee KR, Luedtke G, Barrett FF. Evaluation of vancomycin use in a pediatric teaching hospital based on CDC criteria. Infect Control Hosp Epidemiol. 1997;18:780-782.
16. Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin Infect Dis. 2003;36:440-446.
17. Saez-Llorens X, Castrejon de Wong MM, Castano E, De Suman O, De Moros D, De Atencio I. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country. Pediatr Infect Dis J. 2000;19:200-206.
18. Lee VW, Lyon DJ, Fung KS, Leung TP, Ng JK, You JH. Impact of guidelines on vancomycin use at a Hong Kong teaching hospital. Am J Health Syst Pharm. 2003;60:949-950.
19. Feucht CL, Rice LB. An interventional program to improve antibiotic use. Ann Pharmacother. 2003;37:646-651.
20. Kumana CR, Ching TY, Kong Y, et al. Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections. Br J Clin Pharmacol. 2001;52:427-432.
21. Richardson LP, Wiseman SW, Malani PN, Lyons MJ, Kauffman CA. Effectiveness of a vancomycin restriction policy in changing the prescribing patterns of house staff. Microb Drug Resist. 2000;6:327-330.
22. Hamilton CD, Drew R, Janning SW, Latour JK, Hayward S. Excessive use of vancomycin: a successful intervention strategy at an academic medical center. Infect Control Hosp Epidemiol. 2000;21:42-45.
23. Lipsky BA, Baker CA, McDonald LL, Suzuki NT. Improving the appropriateness of vancomycin use by sequential interventions. Am J Infect Control. 1999;27:84-91.
24. Fridkin SK, Lawton R, Edwards JR, Tenover FC, McGowan JE Jr, Gaynes RP. Monitoring antimicrobial use and resistance: comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg Infect Dis. 2002;8:702-707.
25. Bolon MK, Arnold AD, Feldman HA, et al. Evaluating vancomycin use at a pediatric hospital: new approaches and insights. Infect Control Hosp Epidemiol. 2005;26:47-55.
26. Ayuthya SK, Malathum K, Matangkasombut OP. Restriction of vancomycin use at a university hospital in Thailand. Am J Health Syst Pharm. 2003;60:1053-1054.
27. Ayuthya SK, Matangkasombut OP, Sirinavin S, Malathum K, Sathapatayavongs B. Utilization of restricted antibiotics in a university hospital in Thailand. Southeast Asian J Trop Med Public Health. 2003;34:179-186.
28. Evans ME, Millheim ET, Rapp RP. Vancomycin use in a university medical center: effect of a vancomycin continuation form. Infect Control Hosp Epidemiol. 1999;20:417-420.
29. Gluck T, Linde HJ, Wiegrebe E, Lehn N, Reng M, Scholmerich J. [Effects of restrictions on use of vancomycin in a German university hospital]. Med Klin (Munich). 2000;95:69-74.
30. Sirinavin S, Suvanakoot P, Sathapatayavongs B, Malatham K. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment. Southeast Asian J Trop Med Public Health. 1998;29:636-642.
31. Keyserling HL, Sinkowitz-Cochran RL, Harris JM 2nd, et al. Vancomycin use in hospitalized pediatric patients. Pediatrics. 2003;112:e104-e11.
32. Paganini H, Staffolani V, Zubizarreta P, Casimir L, Lopardo H, Luppino V. Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors. Eur J Cancer. 2003;39:1284-1289.